Veeva Systems Posts Higher Revenue, Operating Income, Net Income, and Diluted EPS on Both the Three-Month and Six-Month Windows in Interim Filing

Bottom line

Veeva Systems Inc. closed the three-month reporting period the three months ended July 31, 2026 and the six-month year-to-date window the six months ended July 31, 2026 with another period of growth on every top-line and bottom-line measure the filing lets us compare, extending a pattern already visible across the prior interim reports we have walked through for other issuers such as Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in Filing and ONEOK Posts Higher Revenue, Operating Income, Net Income and Diluted EPS Year-Over-Year in Interim Filing. Revenue from Contract with Customer, Excluding Assessed Tax reached $927,963,000 for the quarter and $1,810,911,000 for the year-to-date, with the prior-year comparatives at $789,081,000 and $1,548,124,000; both comparisons are authorized as directionally higher, leaving Veeva's headline commercial momentum on the same trajectory readers saw in the prior interim cycle.

Profitability widened alongside the top line. Operating Income (Loss) was $275,018,000 for the quarter and $548,130,000 for the year-to-date, against $195,908,000 and $429,640,000 respectively, with both quarter-over-quarter and half-year-over-half-year moves authorized as higher. Net Income (Loss) Attributable to Parent came in at $273,429,000 for the three-month window and $534,365,000 for the six-month window, against $200,309,000 and $428,499,000; the filing preserves a profit-to-profit transition on both windows, with the half-year move explicitly authorized as an increase. Earnings Per Share, Diluted was $1.66 per diluted share for the quarter and $3.22 per diluted share for the year-to-date, against $1.19 per diluted share and $2.56 per diluted share, again with a profit-to-profit transition authorized on both windows and a higher direction on each.

The reporting context is the periodic filing identified by 10-Q covering period-ended-2026-07-31, filed under accession 0001393052-26-000036 by entity VEEVA SYSTEMS INC (CIK 0001393052, ticker VEEV). The narrative the company itself supplies frames Veeva as the leading provider of industry cloud solutions for the global life sciences industry, spanning R&D and Quality Solutions alongside Commercial Solutions, with Veeva AI layered onto the Vault platform; that self-description establishes the commercial perimeter but is not, on its own, a driver of any reported figure. The notes referenced in the filing that bear on this opening read are Note 1 (Summary of Business and Significant Accounting Policies), Note 7 (Income Taxes, where the effective tax-rate disclosure lives for the three months referenced) and Note 8 (Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable), which together set the boundary between revenue timing and earnings recognition without supplying a causal account.

The filing evidence does not attribute this change to any single cause.

Financial performance

Veeva Systems Inc., identified in this 10-Q filing for period-ended-2026-07-31 under accession 0001393052-26-000036, operates as a cloud-software provider serving the global life sciences industry, and the current-period results below describe how its top line, operating profitability, and bottom line compared with the same windows a year earlier.

Reported facts - Revenue from Contract with Customer, Excluding Assessed Tax was $927,963,000 USD for the three months ended July 31, 2026, and $1,810,911,000 USD for the six months ended July 31, 2026; the prior-year comparatives were $789,081,000 USD and $1,548,124,000 USD for the three months ended July 31, 2025 and the six months ended July 31, 2025 respectively. - Operating Income (Loss) was $275,018,000 USD for the three months ended July 31, 2026 versus $195,908,000 USD for the three months ended July 31, 2025, and $548,130,000 USD for the six months ended July 31, 2026 versus $429,640,000 USD for the six months ended July 31, 2025. - Net Income (Loss) Attributable to Parent was $273,429,000 USD for the three months ended July 31, 2026 versus $200,309,000 USD for the three months ended July 31, 2025, and $534,365,000 USD for the six months ended July 31, 2026 versus $428,499,000 USD for the six months ended July 31, 2025. - Earnings Per Share, Diluted was $1.66 per diluted share USD/SHARES for the three months ended July 31, 2026 versus $1.19 per diluted share USD/SHARES for the three months ended July 31, 2025, and $3.22 per diluted share USD/SHARES for the six months ended July 31, 2026 versus $2.56 per diluted share USD/SHARES for the six months ended July 31, 2025.

Management explanations - Management describes Veeva as the leading provider of industry cloud solutions for the global life sciences industry, spanning applications, agents, data, and consulting across R&D and commercialization, with Veeva AI layering agentic capabilities onto the Vault platform. - The interim statements are unaudited and have been prepared under US GAAP and SEC interim reporting rules; the January (omitted) balance sheet was derived from the audited statements, and there have been no material changes to significant accounting policies since the annual report. - Management notes an Ostro acquisition completed in March (omitted), an engagement platform for life sciences delivering AI-driven compliant answers to patients and doctors, with identifiable intangibles across trade names and trademarks, developed technology, and customer relationships, and goodwill not deductible for income tax. - Amortization of deferred sales-commission costs is recognized within sales and marketing expense; the cited note describes the deferred-cost policy but omits the exact amortization figures for both quarter and half-year periods.

Analyst inference - On the year-over-year view, Revenue from Contract with Customer, Excluding Assessed Tax increased from the three months ended July 31, 2025 to the three months ended July 31, 2026 and from the six months ended July 31, 2025 to the six months ended July 31, 2026, a profit-to-profit top-line expansion. - Operating Income (Loss) moved higher year-over-year on both the three-month and six-month windows, transitioning profit to profit in each case. - Net Income (Loss) Attributable to Parent and Earnings Per Share, Diluted both stepped up on the quarter and the half-year, again maintaining a profit-to-profit profile across each comparison. - A similar profit-to-profit pattern across top line, operating line, and bottom line is visible in other recent Lizely Finance coverage, such as Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in Filing, although underlying mix and segment drivers differ.

Counter-evidence and risks - The MD&A risk-factor section (Item 1A) and the controls-and-procedures discussion (Item 4) provide no itemized reconciliation tying the period-over-period changes to specific cost lines, so any narrative attributing gains to a single lever would be unsupported.

Unknowns - Guidance expectations for the remainder of the fiscal year are not quantified in the cited excerpts; forward-looking statements are presented only as of the report date with no updated outlook figures. - The filing evidence does not attribute this change to any single cause. - The filing evidence contains no peer or industry comparison.

Operating drivers and segments

Veeva Systems Inc. presents its results through a single operating footprint, but the filing describes that footprint as two paired solution families built around its industry cloud platform. The Commercial Solutions grouping, comprising Veeva Commercial Cloud and Veeva Data Cloud, is positioned for engagement with healthcare professionals and organizations, media planning, and marketing execution. The R&D and Quality Solutions grouping, comprising Veeva Development Cloud and Veeva Quality Cloud, addresses clinical, regulatory, quality, and safety workflows across the product life cycle. A separate line of business supports clinical research sites, and Veeva AI layers agentic capability onto the Vault platform and across both solution families. The filing does not allocate revenue, operating income, or headcount between these solution families, so segment-level margin or growth cannot be read directly from the cited notes. Reported revenue from contracts with customers, excluding assessed tax, was $927,963,000 USD for the three-month reporting period the three months ended July 31, 2026, compared with $789,081,000 USD for the three months ended July 31, 2025. For the six-month year-to-date window, revenue was $1,810,911,000 USD for the six months ended July 31, 2026, against $1,548,124,000 USD for the six months ended July 31, 2025. Operating income for the three-month window was $275,018,000 USD versus $195,908,000 USD, and for the six-month window it was $548,130,000 USD versus $429,640,000 USD.

Management frames Veeva as the leading industry cloud provider for global life sciences, spanning applications, agents, data, and consulting from research and development through commercialization, with Veeva AI positioned to add agentic capability to the Vault platform and deepen industry-specific agents across the Commercial and R&D and Quality solution families. The forward-looking statements section cautions that any commentary on possible or assumed future results, market sizing, competitive position, growth opportunities, and product capability is subject to known and unknown risks detailed under Risk Factors and Management's Discussion and Analysis. The summary of business and significant accounting policies notes that the interim financial statements reflect normal recurring adjustments, are not necessarily indicative of full-year results, and are read alongside the Annual Report on Form (omitted) for the fiscal year ended January (omitted). Management states there have been no changes to significant accounting policies that have had a material impact on the condensed consolidated financial statements, and that it is currently evaluating a recent FASB update on disaggregation of income statement expenses to determine its impact on disclosures. The cited note on accounting policies (Note 1) carries that disclosure. No management attribution is offered in the cited evidence for the specific movement in revenue or operating income between the current and prior-year windows. The filing evidence does not attribute this change to any single cause.

On the independent side, the authorized year-over-year direction on revenue and operating income for both the three-month and six-month windows is higher, and the authorized transition on operating income for both windows is profit to profit, consistent with the directional signs already disclosed. The filing does not isolate which solution family, geography, or customer cohort drove that movement, and it offers no peer or industry benchmark against which the magnitudes can be triangulated. The filing evidence contains no peer or industry comparison. Readers looking for a parallel pattern of profit-to-profit growth on both the quarter and year-to-date windows can cross-check the framing in Lizely Finance Earnings Analysis — UFP TECHNOLOGIES INC Interim Filing: Profit-to-Profit Growth on Both Windows.

Cash flow and capital

- Veeva's reported figures for VEEVA SYSTEMS INC in 10-Q for period-ended-2026-07-31 show an operating-cash-flow profile that is the centerpiece of the liquidity story. Net Cash Provided by (Used in) Operating Activities reached $1,365,825,000 USD in the six months ended July 31, 2026, an increase from $1,115,591,000 USD in the six months ended July 31, 2025. The directional comparison is authorized as an increase.

- Investing activities continued to absorb cash. Net Cash Provided by (Used in) Investing Activities was -$452,251,000 USD in the current six-month window, tracked against -$441,379,000 USD a year earlier. The authorized comparison describes both periods as negative, with a decrease in the headline value. The filing evidence does not attribute this change to any single cause.

- Financing flipped sign. Net Cash Provided by (Used in) Financing Activities moved from $136,069,000 USD (positive) in the prior-year six-month window to -$521,834,000 USD (negative) in the six months ended July 31, 2026, an authorized directional decrease. That swing sits alongside a step-up in capital returns to shareholders, with Payments for Repurchase of Common Stock rising from $0 USD (effectively zero) to $472,673,000 USD in the current six months, the authorized comparison being an increase.

- The period-end balance sheet anchors the snapshot. Cash and Cash Equivalents, at Carrying Value stood at $1,812,012,000 USD as of the balance sheet date of July 31, 2026, with Accounts Receivable, after Allowance for Credit Loss, Current at $496,677,000 USD and Accounts Payable, Current at $35,977,000 USD on the same balance sheet date. The filing evidence does not attribute this change to any single cause.

- Capital-allocation narrative focuses on shareholder returns. The buyback step-up is the most visible signal, executed alongside a financing outflow rather than a financing inflow. Operating cash conversion remained positive, which keeps the working-capital backdrop supportive of further capital returns even as investing continues to absorb liquidity. The filing evidence contains no peer or industry comparison.

- Independent observer interpretation: the operating-to-financing contrast (positive operating cash funding a larger buyback within a financing outflow) is the structural message; the investing line continues to reflect deployment of liquidity rather than a release of funds. The filing evidence does not attribute this change to any single cause.

- Cross-filing note for related sector context, see Mercury Systems Swings to Operating Profit on Higher Revenue, but Net Loss Persists for the Twelve-Month Period.

Peer and historical context

- Top-line growth held up across both windows, with Revenue from Contract with Customer, Excluding Assessed Tax running higher year-over-year for both the three-month reporting period and the six-month year-to-date period. - Profitability scaled with revenue on both windows: Operating Income (Loss) was higher than the prior-year comparative for both the three-month reporting period and the six-month year-to-date period, and Net Income (Loss) Attributable to Parent was higher than the prior-year comparative on both windows as well, with diluted earnings per share similarly higher year-over-year on both windows. - Cash conversion strengthened versus the prior-year comparative, as Net Cash Provided by (Used in) Operating Activities ran higher for the six-month year-to-date period. - The directional pattern across revenue, operating income, net income and operating cash flow on the year-to-date window is consistent with what readers can verify in Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in Filing and ONEOK Posts Higher Revenue, Operating Income, Net Income and Diluted EPS Year-Over-Year in Interim Filing, both of which also describe interim filings where all four headline lines moved higher at once; Veeva's profile tracks that pattern on the year-to-date window. - On the quarter-only window, the same four-way higher pattern also appears, so the half-year improvement is not a story carried solely by the second quarter of the prior fiscal year fading from the base.

- The filing evidence does not attribute this change to any single cause. - The filing evidence contains no peer or industry comparison. - The cited note on Income Taxes describes the effective tax rate moving on both windows with offsetting components, and that structural mix on reported net income is not isolated from the year-over-year move in the catalog evidence.

Scenario analysis

- In a continuation case, the company's subscription-centric model keeps translating backlog into recurring billings, leaving both revenue and net income on a profit-to-profit growth path on the three-month and six-month windows. - Reported revenue of $927,963,000 USD for the three months ended July 31, 2026 runs higher than the prior-year quarter revenue of $789,081,000 USD for the three months ended July 31, 2025, mirroring the six-month reading of $1,810,911,000 USD versus $1,548,124,000 USD for the six months ended July 31, 2025. - Net income follows the same shape, with $273,429,000 USD for the three months ended July 31, 2026 above $200,309,000 USD for the three months ended July 31, 2025, and the half-year net income of $534,365,000 USD running above the prior-year six-month net income of $428,499,000 USD for the six months ended July 31, 2025.

- A constructive read layers the favorable effective-tax-rate shift referenced in Note 7 — the OBBBA-driven increase in foreign-derived deduction eligible income, partly offset by discrete tax deficiencies on equity compensation — onto continued subscription billings, lifting both bottom-line figures further without changing the qualitative trajectory. - The same constructive path is reinforced by Note 8, where deferred revenue recognized during the quarter and the year-to-date period, combined with the noncancellable subscription backlog that is expected to be recognized within the cited forward window, gives visibility into a higher run-rate of recognized revenue. - Note 5 preserves balance-sheet capacity for further bolt-on deals of the kind described in Note 2, where goodwill recognized at acquisition is attributed to expected synergies rather than to tax-deductible basis, leaving optionality for expansion-led upside.

- A cautious read keeps the same direction but narrows the gap: revenue still registers higher on both the three-month and six-month comparisons, and net income remains in profit on both windows, yet the deferred-revenue mix in Note 8 and the lease and stock-compensation cost base in Note 9 and Note 10 compress margin conversion. - The half-year and quarter net income readings cited above would each print lower than their base-case counterparts under this scenario, while staying above the respective prior-year comparative net income figures for the three months ended July 31, 2025 and the six months ended July 31, 2025. - The forward obligations flagged in Note 8 — most of the allocated transaction price expected to be recognized within the cited near-term window — magnify the risk that any softening in subscription renewals would quickly flow into the next reporting cadence.

Risks and what to watch

- Reported risks: The risk-factor discussion lives in the filing's second part under Item 1A, and investors should re-read it for the current period framing rather than relying on carry-over language. No new legal proceedings are flagged in Item 1, and Item 4 simply confirms that controls-and-procedures disclosure was filed without naming a specific weakness. - Management explanations: Management attributes the year-over-year reduction in the effective tax rate for both the three- and six-month windows to a larger foreign-derived deduction eligible income benefit under the OBBBA provisions, partially offset by discrete tax deficiencies tied to equity compensation.

Management also describes fair-value pricing for cash equivalents using Level 1 quoted prices and Level 2 other observable inputs, and confirms that foreign currency forward contracts are marked to market through other income, net, with no hedge designation. - Analyst inference: Revenue from Contract with Customer, Excluding Assessed Tax rose versus the prior year on both the three-month window ($927,963,000 vs. $789,081,000) and the six-month window ($1,810,911,000 vs.

$1,548,124,000). Net Income (Loss) Attributable to Parent likewise moved higher on both the quarter ($273,429,000 vs. $200,309,000) and the year-to-date ($534,365,000 vs.

$428,499,000). The base of recurring revenue is hinted at by Note 8, where management states that the transaction price allocated to remaining performance obligations on subscription contracts longer than a year is not significant and is largely captured in deferred revenue expected to convert over a relatively short forward window. Deferred-revenue rolloff language in the same note is referenced as a smoothing mechanism, but the dollar magnitudes are not carried in this section's catalog.

- Counter-evidence: The effective-tax-rate tailwind is policy-driven and may not repeat at the same intensity if the FDDEI mix migrates; the disclosed offsetting discrete tax deficiencies show that equity-compensation outcomes can blunt the benefit in any given quarter. Deferred revenue conversion is described qualitatively and excludes any quantified backlog, leaving the conversion cadence as a soft signal rather than a hard cushion. Note 5 carries goodwill and intangibles balances that can become an impairment story if an acquired business underperforms, including the Ostro acquisition discussed in Note 2.

Note 9 highlights a global operating-lease footprint with optional extension terms, adding a structural cost layer if utilization softens. - Unknowns: The filing evidence does not attribute this change to any single cause. The filing evidence does not disclose segment-level detail for this dimension.

The filing evidence contains no peer or industry comparison. - Metrics to watch next period: Revenue growth on both windows, the trajectory of $273,429,000 and $534,365,000 against their prior-year comparables, the effective tax rate given the OBBBA FDDEI mechanics, deferred-revenue conversion velocity per Note 8, fair-value remeasurement impacts flowing through other income, and any update to the goodwill and intangibles picture in Note 5. A useful cross-check on the profit-to-profit pattern is the UFP TECHNOLOGIES INC Interim Filing analysis, which frames a similar directional outcome for readers comparing interim prints.